Litcius/Paper detail

The current state of tobacco cessation treatment

Humberto Choi, Jorge Ataucuri-Vargas, Charlie Lin, Amanda M. Singrey

2021Cleveland Clinic Journal of Medicine42 citationsDOIOpen Access PDF

Abstract

Nicotine addiction and dependence is a chronic relapsing disease driven by addiction to nicotine. Proactive treatment for all tobacco users, regardless of their readiness to quit, is recommended. First-line tobacco cessation medications include nicotine replacement therapy, bupropion, and varenicline. Comprehensive treatment with behavioral interventions and pharmacologic therapy increases success rates of smoking cessation. Although there are many popular alternative treatments, they should not replace or delay the use of known effective therapies.

Topics & Concepts

VareniclineMedicineBupropionSmoking cessationNicotine replacement therapyAddictionNicotine AddictionNicotineTobacco harm reductionNicotine dependencePsychiatryPsychological interventionTobacco useIntensive care medicineEnvironmental healthPopulationPathologySmoking Behavior and CessationNicotinic Acetylcholine Receptors StudyObesity, Physical Activity, Diet
The current state of tobacco cessation treatment | Litcius